Cardlytics Beats on EPS, but the $36.9M Revenue Miss Keeps the Pressure On

Cardlytics faces a mixed signal into second-quarter results

Cardlytics is set to release second-quarter results today after market close. The setup is straightforward: investors are already aware that management beat EPS expectations, but they also know revenue came up short. That is not a clean positive signal. It leaves the market weighing whether Cardlytics' simplification story can offset weak top-line momentum before patience runs thin.

Why the EPS beat and revenue miss send different signals

• The bull case: An EPS beat suggests Cardlytics still has some cost discipline and potential operating leverage. If revenue is stabilizing, investors focused on efficiency may view that favorably.
• The bear case: If revenue continues to soften, a better earnings-per-share figure says less about business recovery and more about expense control or reporting structure.
• Our thesis: Treat this as mixed evidence. One EPS beat does not settle the story while revenue remains soft. The more important question is whether the streamlined model is creating real traction rather than merely reducing costs.
• What investors need to hear on the call: Management needs to connect current results to a more stable revenue path. Without that, the market is unlikely to give lasting multiple expansion to a partial recovery story.

The key issue is whether improvement is operational or structural

The more important debate is not whether Cardlytics beat on earnings. It is whether that beat came from a better business or a cheaper one.

Operational improvement versus cheaper reporting

There is a mechanical reason EPS can improve even while the underlying business is still stabilizing. In Q1, Cardlytics reported revenue from continuing operations of $34.3 million, but it also successfully completed the divestiture of Bridg on March 24, 2026 and subsequently liquidated PAR shares, further bolstering the balance sheet. Those steps can strengthen the balance sheet and affect earnings metrics without proving that the core advertising platform has fully recovered. Part of the improvement story may reflect simplification, not pure operating momentum.

That distinction matters. If the company looks healthier because it shed assets and streamlined its structure, that is meaningful housekeeping, but it is not the same as confirming a demand turnaround.

What the available numbers suggest

The Q1 data points to a smaller business, not yet a clearly revived one. Revenue from continuing operations was $34.3 million, while billings from continuing operations were $58.1 million and adjusted contribution from continuing operations was $19.7 million. Those figures show progress in execution, but they also show a significantly smaller base than a year earlier.

That is why the mechanism matters. The company is running a leaner structure, and that can improve EPS even before the core platform demonstrates durable growth.

What matters most for the stock

This looks more like evidence that the bleed may be slowing than proof of a full recovery. That is worth noting, but it does not by itself justify a clean growth rerating.